��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Cancer Risk among Patients with Multiple Sclerosis during the Treatment Era: The CARIMS Study Update

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 135

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
	No disclosure on file
Gilles Defer, MD (Hopital Cote De Nacre)	Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
	No disclosure on file
Lucien Rumbach, MD (Hopital Jean Minjoz)	No disclosure on file
	No disclosure on file
Patricia Tourniaire, MD (C.H. Heri Duffaut)	No disclosure on file
	No disclosure on file